Cargando…
Donor-derived Cell-free DNA Kinetics Post-kidney Transplant Biopsy
BACKGROUND. Donor-derived cell-free DNA (dd-cfDNA) has generated interest as a biomarker for kidney injury including transplant (KT) rejection. It is possible that the KT biopsy procedure can cause the release of dd-cfDNA, therefore affecting the reliability of this assay in the postbiopsy period. W...
Autores principales: | Kyeso, Yousuf, Bhalla, Anshul, Smith, Alyssa P., Jia, Yaqi, Alakhdhair, Safa, Ogir, Stephanie C., Abuzeineh, Mohammad, Brennan, Daniel C., Alasfar, Sami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154469/ https://www.ncbi.nlm.nih.gov/pubmed/34056078 http://dx.doi.org/10.1097/TXD.0000000000001149 |
Ejemplares similares
-
Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration
por: Lakhani, Laila, et al.
Publicado: (2021) -
Prospective Assessment of the Prevalence of Enter Hyperoxalosis in Kidney Transplant Candidates
por: Mejia, Christina, et al.
Publicado: (2023) -
Procurement Biopsy Findings Versus Kidney Donor Risk Index for Predicting Renal Allograft Survival
por: Hall, Isaac E., et al.
Publicado: (2018) -
Kidney Donors With Diabetes: Renal Biopsy Findings at Time of Transplantation and Their Significance
por: Truong, Luan D., et al.
Publicado: (2019) -
Donor-derived Cell-free DNA and the Prediction of BK Virus-associated Nephropathy
por: Kant, Sam, et al.
Publicado: (2020)